Filing Flows › Wave Life Sciences (WVE) › Recalls, complaints & regulation
Wave Life Sciences (WVE): clinical trials
Wave Life Sciences (WVE) beyond its filings: 4 active clinical trials.
Wave Life Sciences' latest quarter
Wave Life Sciences, Q3 2026: revenue $13.2M (+73% year over year), operating margin -502.0%, net loss $61.9M, operating cash flow −$60.1M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Wave Life Sciences have?
4 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.